BNP Paribas Financial Markets
BHVN

BNP Paribas Financial Markets’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

BNP Paribas Financial Markets’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,295
Closed -$5.49M – 5030
2022
Q3 		$5.49M Buy
36,295
+22,411
+161% +$3.32M 0.01% 1323
2022
Q2 		$2.02M Buy
13,884
+8,242
+146% +$1.05M ﹤0.01% 1751
2022
Q1 		$669K Sell
5,642
-7,851
-58% -$979K ﹤0.01% 2583
2021
Q4 		$1.86M Buy
13,493
+2,281
+20% +$290K ﹤0.01% 2099
2021
Q3 		$1.56M Buy
11,212
+9,223
+464% +$1.15M ﹤0.01% 2076
2021
Q2 		$193K Sell
1,989
-4,145
-68% -$336K ﹤0.01% 2877
2021
Q1 		$419K Sell
6,134
-1,146
-16% -$92.7K ﹤0.01% 2659
2020
Q4 		$624K Sell
7,280
-4,004
-35% -$339K ﹤0.01% 2345
2020
Q3 		$734K Buy
11,284
+7,183
+175% +$471K ﹤0.01% 1975
2020
Q2 		$300K Sell
4,101
-39,620
-91% -$2.11M ﹤0.01% 2319
2020
Q1 		$1.49M Buy
43,721
+38,810
+790% +$1.77M ﹤0.01% 1657
2019
Q4 		$267K Sell
4,911
-858
-15% -$42.5K ﹤0.01% 2824
2019
Q3 		$241K Buy
5,769
+2,294
+66% +$96.9K ﹤0.01% 2656
2019
Q2 		$152K Sell
3,475
-3,025
-47% -$171K ﹤0.01% 2784
2019
Q1 		$335K Buy
+6,500
New +$281K ﹤0.01% 2365
2018
Q4 		– Sell
-873
Closed -$32.8K – 4568
2018
Q3 		$32.8K Hold
873
– – ﹤0.01% 3214
2018
Q2 		$34.5K Sell
873
-5,426
-86% -$172K ﹤0.01% 3271
2018
Q1 		$162K Buy
6,299
+4,121
+189% +$123K ﹤0.01% 2916
2017
Q4 		$58.8K Buy
2,178
+732
+51% +$20.2K ﹤0.01% 3576
2017
Q3 		$54.1K Buy
1,446
+398
+38% +$12.1K ﹤0.01% 3105
2017
Q2 		$26.2K Buy
+1,048
New +$24.1K ﹤0.01% 3510

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

BNP Paribas Financial Markets's BHVN Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 36,295 shares — an estimated $5.49M sold.

BNP Paribas Financial Markets first reported a position in BHVN in Q2 2017 and held it in 21 quarters. The position peaked at $5.49M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 36,295 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $5.49M.
  • BNP Paribas Financial Markets first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 21 quarters.
  • BNP Paribas Financial Markets's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5.49M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.